Список литературы

Поставить закладку

Hoffman JIE, Kaplan S. The incidence of congenital heart disease. J Am Coll Cardiol. 2002;39:1890–900.
Kouchoukos N.T., Blackstone E.H., Hanley F.L., Kirklin J.K. Kirklin/Barratt-Boyes cardiac surgery: morphology, diagnostic criteria, natural history, techniques, results, and indications. – 4th ed. Philadelphia: Elsevier; 2013.
Du Z.D., Hijazi Z.M., Kleinman C.S., Silverman N.H., Larntz K. Comparison between transcatheter and surgical closure of secundum atrial septal defect in children and adults: results of a multicenter nonrandomized trial. J. Am. Coll. Cardiol. 2002; 39: 1836–44.
Loscalzo J. Paradoxical embolism: clinical presentation, diagnostic strategies, and therapeutic options. Am Heart J. 1986; 112: 141–5.
Ward R, Jones D, Haponik EF. Paradoxical embolism. An underrecognized problem. Chest. 1995;108: 549 –58.
Waltz DA, Boucek MM, Edwards LB, et al. Registry of the International Society for Heart and Lung Transplantation: ninth official pediatric lung and heart-lung transplantation report–2006. J Heart Lung Transplant. 2006; 25: 904 –11.
Choong CK, Meyers BF, Battafarano RJ, et al. Lung cancer resection combined with lung volume reduction in patients with severe emphysema. J Thorac Cardiovasc Surg. 2004; 127: 1323–31.
Fuster V, Brandenburg RO, McGoon DC, Giuliani ER. Clinical approach and management of congenital heart disease in the adolescent and adult. Cardiovasc Clin. 1980; 10: 161–97.
Rigby M. Atrial septal defect. In: Diagnosis and Management of Adult Congenital Heart Disease. London: Churchill Livingston, 2003.
Ballester M, Presbitero P, Foale R, Rickards A, McDonald L. Prolapse of the mitral valve in secundum atrial septal defect: a functional mechanism. Eur Heart J. 1983; 4: 472– 6.
Silka MJ, Rice MJ. Paradoxic embolism due to altered hemodynamic sequencing following transvenous pacing. Pacing Clin Electrophysiol. 1991; 14: 499 –503.
Ward R, Jones D, Haponik EF. Paradoxical embolism. An underrecognized problem. Chest. 1995; 108: 549 –58.
Konstantinides S, Geibel A, Olschewski M, et al. A comparison of surgical and medical therapy for atrial septal defect in adults. N Engl J Med. 1995; 333: 469 –73.
Craig RJ, Selzer A. Natural history and prognosis of atrial septal defect. Circulation. 1968; 37: 805–15.
Fraker TD Jr, Harris PJ, Behar VS, Kisslo JA. Detection and exclusion of interatrial shunts by two-dimensional echocardiography and peripheral venous injection. Circulation. 1979; 59: 379–84.
Freed MD, Nadas AS, Norwood WI, Castaneda AR. Is routine preoperative cardiac catheterization necessary before repair of secundum and sinus venosus atrial septal defects? J Am Coll Cardiol. 1984; 4: 333– 6.
Shub C, Tajik AJ, Seward JB, Hagler DJ, Danielson GK. Surgical repair of uncomplicated atrial septal defect without “routine” preoperative cardiac catheterization. J Am Coll Cardiol. 1985; 6: 49 –54.
Kronzon I, Tunick PA, Freedberg RS, Trehan N, Rosenzweig BP, Schwinger ME. Transesophageal echocardiography is superior to transthoracic echocardiography in the diagnosis of sinus venosus atrial septal defect. J Am Coll Cardiol. 1991; 17: 537– 42.
Prystowsky EN, Benson DW Jr, Fuster V, et al. Management of patients with atrial fibrillation. A statement for healthcare professionals. From the Subcommittee on Electrocardiography and Electrophysiology, American Heart Association. Circulation. 1996; 93: 1262–77.
Fischer G, Stieh J, Uebing A, Hoffmann U, Morf G, Kramer HH. Experience with transcatheter closure of secundum atrial septal defects using the Amplatzer septal occluder: a single centre study in 236 consecutive patients. Heart. 2003; 89: 199 –204.
Dhillon R, Thanopoulos B, Tsaousis G, Triposkiadis F, Kyriakidis M, Redington A. Transcatheter closure of atrial septal defects in adults with the Amplatzer septal occluder. Heart. 1999; 82: 559–62.
Morris CD, Reller MD, Menashe VD. Thirty-year incidence of infective endocarditis after surgery for congenital heart defect. JAMA. 1998; 279: 599–603.
Cooper WO, Hernandez-Diaz S, Arbogast PG, et al. Major congenital malformations after first-trimester exposure to ACE inhibitors. N Engl J Med. 2006; 354: 2443–51.
Schaefer C, Hannemann D, Meister R, et al. Vitamin K antagonists and pregnancy outcome. A multi-centre prospective study. Thromb Haemost. 2006; 95: 949 –57.
Famuyide AO, Hopkins MR, El-Nashar SA, et al. Hysteroscopic sterilization in women with severe cardiac disease: experience at a tertiary center. Mayo Clin Proc. 2008; 83: 431– 8.
Epstein AE, Di Marco JP, Ellenbogen KA, et al. ACC/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnomalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to revise the ACC/AHA/NASPE 2002 guideline update for implantation of cardiac pacemakers and antiarrhythmia devices). J Am Coll Cardiol. 2008; 51: e1– 62.
Khositseth A, Danielson GK, Dearani JA, Munger TM, Porter CJ. upraventricular tachyarrhythmias in Ebstein anomaly: management and outcome. J Thorac Cardiovasc Surg. 2004; 128: 826 –33.
Chetaille P, Walsh EP, Triedman JK. Outcomes of radiofrequency catheter ablation of atrioventricular reciprocating tachycardia in patients with congenital heart disease. Heart Rhythm. 2004; 1: 168 –73.
Nakagawa H, Shah N, Matsudaira K, et al. Characterization of reentrant circuit in macroreentrant right atrial tachycardia after surgical repair of congenital heart disease: isolated channels between scars allow “focal” ablation. Circulation. 2001; 103: 699 –709.
Anand N, McCrindle BW, Chiu CC, et al. Chronotropic incompetence in young patients with late postoperative atrial flutter: a case-control study. Eur Heart J. 2006; 27: 2069 – 73.
Walker RE, Moran AM, Gauvreau K, Colan SD. Evidence of adverse ventricular interdependence in patients with atrial septal defects. Am J Cardiol. 2004; 93: 1374 –7, A6.
Daliento L, Somerville J, Presbitero P, et al. Eisenmenger syndrome. Factors relating to deterioration and death. Eur Heart J. 1998; 19: 1845–55.
Siu SC, Sermer M, Harrison DA, et al. Risk and predictors for pregnancy related complications in women with heart disease. Circulation. 1997; 96: 2789–94.
Benson DW, Sharkey A, Fatkin D, et al. Reduced penetrance, variable expressivity, and genetic heterogeneity of familial atrial septal defects. Circulation. 1998; 97: 2043– 8.
Schott JJ, Benson DW, Basson CT, et al. Congenital heart disease caused by mutations in the transcription factor NKX2-5. Science. 1998; 81: 108 –11.
Whittemore R, Wells JA, Castellsague X. A second-generation study of 427 probands with congenital heart defects and their 837 children. J Am Coll Cardiol. 1994; 23: 1459– 67.
Basson CT, Bachinsky DR, Lin RC, et al. Mutations in human TBX5 [corrected] cause limb and cardiac malformation in Holt-Oram syndrome. Nat Genet. 1997; 15: 30 –5.
Basson CT, Solomon SD, Weissman B, et al. Genetic heterogeneity of heart-hand syndromes. Circulation. 1995; 91: 1326 –9.
Holt M, Oram S. Familial heart disease with skeletal malformations. Br Heart J. 1960; 22: 236–42.
Helber U, Baumann R, Seboldt H, Reinhard U, Hoffmeister HM. Atrial septal defect in adults: cardiopulmonary exercise capacity before and 4 months and 10 years after defect closure. J Am Coll Cardiol. 1997; 29: 1345–50.
Graham TP Jr, Bricker JT, James FW, Strong WB. 26th Bethesda conference: recommendations for determining eligibility for competition in athletes with cardiovascular abnormalities. Task Force 1: congenital heart disease. J Am Coll Cardiol. 1994; 24: 867–73.